FDA Adverse Event Other Summary report: N

EVOLIS MICROPLATE SYSTEM

MDR report key: 2261442 · Received September 21, 2011

Report

Report Number
3022521-2011-00003
Event Type
Other
Date Received
September 21, 2011
Date of Event
August 23, 2011
Report Date
September 21, 2011
Manufacturer
BIO-RAD LABORATORIES, INC.
Product Code
LOL
PMA / PMN Number
K092353
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Description of Event or Problem · 1

ON (B)(6) 2011, A CUSTOMER CONTACTED THE BIO-RAD LABORATORIES TECHNICAL SUPPORT DEPARTMENT TO REQUEST HELP IN INTERPRETING A RESULT FROM A PT SAMPLE WHEN RUNNING THE BIO-RAD TOXOPLASMA IGG EIA ASSAY, ON THE EVOLIS MICROPLATE SYSTEM. THE EVOLIS IS A 4-PLATE SELF-CONTAINED MICROPLATE PROCESSOR SYSTEM DESIGNED FOR USE WITH EIA ASSAYS. THE CUSTOMER REPORTED THE PT SAMPLE RESULT VALUE WAS HIGHER THAN THE TOXOPLASMA IGG CALIBRATOR 1 VALUE FOR THE ASSAY BUT THE RESULT REPORTED WAS NEGATIVE. THE CUSTOMER STATED THAT A PREVIOUS PT SAMPLE VALUE WAS HIGHER THAN THE TOXOPLASMA IGG CALIBRATOR 1 VALVE BUT THE REPORTED RESULT WAS POSITIVE. TECHNICAL SUPPORT REVIEWED THE DATA SENT BY THE CUSTOMER AND DISCOVERED THAT THE CUSTOMER HAD ENTERED INCORRECT VALUES FOR THE MINIMUM AND MAXIMUM POSITIVE CONTROL TOXOPLASMA IGG CALIBRATOR 1, AND TOXOPLASMA IGG CALIBRATOR 2. THE CUSTOMER ENTERED THE INDEX VALUES INSTEAD OF THE IU/ML AS STATED IN THE EVOLIS MATRM FOR THE TOXOPLASMA IGG EIA ASSAY. TECHNICAL SUPPORT INFORMED THE CUSTOMER THE VALUES ENTERED WERE INCORRECT AND INSTRUCTED THE CUSTOMER TO FOLLOW THE MATRM; WHICH TELLS THE CUSTOMER WHAT SHOULD BE ENTERED. TECHNICAL SUPPORT REQUESTED PREVIOUS RUN DATA FOR REVIEW TO SEE IF THE ERROR OCCURRED IN PREVIOUS RUNS. THE REVIEW OF THE DATA SHOWED 4 PT SAMPLES WHICH SHOULD HAVE BEEN REPORTED AS POSITIVE WERE REPORTED AS NEGATIVE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 EVOLIS MICROPLATE SYSTEM 4 PS (FOUR PLATE SYSTEM) LOL BIO-RAD LABORATORIES, INC. EVOLIS

Patients

Seq Age Sex Outcome Treatment
1